Metabolic Syndrome Associated with Tobacco and Caffeine Products Use Among Refugee Adolescents: Risk of Dyslipidemia
Basma Damiri,1 Omar Khatib,2 Zaher Nazzal,3 Diala Sanduka,2 Siwar Igbaria,2 Ammar Thabaleh,2 Ahmad Farhoud,2 Lubna Saudi,3 Souad Belkebir,3 Rayyan Al Ali,4 Mohammed Alili,2 Mahmoud Hamdan,5 Omar A Safarini,2 Omar Younis2 1Medicine & Health Science Faculty, Drug, and Toxicology Division, An-Najah...
Guardado en:
Autores principales: | Damiri B, Khatib O, Nazzal Z, Sanduka D, Igbaria S, Thabaleh A, Farhoud A, Saudi L, Belkebir S, Al Ali R, Alili M, Hamdan M, Safarini OA, Younis O |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/56d334f53acc4b6988a792e9e27049bd |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Eating Disorders and the Use of Cognitive Enhancers and Psychostimulants Among University Students: A Cross-Sectional Study
por: Damiri B, et al.
Publicado: (2021) -
Associations of dipping and non-dipping hypertension with cardiovascular diseases in patients with dyslipidemia
por: Siping Dai, et al.
Publicado: (2019) -
Pathophysiological rationale for the results of atherogenic dyslipidemia simulation in rats
por: V. G. Banzaraksheev
Publicado: (2016) -
Pitolisant, a wake‐promoting agent devoid of psychostimulant properties: Preclinical comparison with amphetamine, modafinil, and solriamfetol
por: Stéphane Krief, et al.
Publicado: (2021) -
Progress of research on dyslipidemia accompanied by nephrotic syndrome
por: Min Tao, et al.
Publicado: (2020)